Emla-Cream as Pain Relief During Pneumococcal Vaccination

Summary

The aim of this intervention study is to compare the efficacy of Emla cream as a pain relief or no pain relief in connection to the first pneumococcal vaccination at the age of three months in Child health care. Primary objective 1.Leads Emla cream as pain relief to children in connection with pneumococcal vaccination at the age of three months to lower pain scores in the use of five items; Face, Legs, Activity, Cry, Consolability (FLACC scale) as a pain measurement instrument?

Timeline

Start

2013-05

Primary completion

2015-11

Completion

2015-11

Drugs

Indications

No indication recorded.